The Future of Prostate Cancer Diagnosis: Biomarkers, Biopsy, Both, or Neither?

被引：1
作者：
Briganti, Alberto [1 ]
Giannarini, Gianluca [2 ]
Klatte, Tobias [3 ]
Catto, James W. [4 ]
Shariat, Shahrokh F. [3 ]
机构：
[1] IRCCS Osped San Raffaele, URI, Unit Urol, Div Oncol, Milan, Italy
[2] Hosp Santa Maria Misericordia, Acad Med Ctr, Urol Unit, Udine, Italy
[3] Med Univ Vienna, Vienna Gen Hosp, Dept Urol, Comprehens Canc Ctr, Vienna, Austria
[4] Univ Sheffield, Acad Urol Unit, Med Sch, Sheffield, S Yorkshire, England
来源：
EUROPEAN UROLOGY FOCUS | 2015年 / 1卷 / 02期
关键词：
D O I：
10.1016/j.euf.2015.07.007
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：97 / 98
页数：2
相关论文
共 17 条
  • [1] Ablin R., 2010, NY TIMES
  • [2] Mortality Results from a Randomized Prostate-Cancer Screening Trial
    Andriole, Gerald L.
    Grubb, Robert L., III
    Buys, Saundra S.
    Chia, David
    Church, Timothy R.
    Fouad, Mona N.
    Gelmann, Edward P.
    Kvale, Paul A.
    Reding, Douglas J.
    Weissfeld, Joel L.
    Yokochi, Lance A.
    Crawford, E. David
    O'Brien, Barbara
    Clapp, Jonathan D.
    Rathmell, Joshua M.
    Riley, Thomas L.
    Hayes, Richard B.
    Kramer, Barnett S.
    Izmirlian, Grant
    Miller, Anthony B.
    Pinsky, Paul F.
    Prorok, Philip C.
    Gohagan, John K.
    Berg, Christine D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) : 1310 - 1319
  • [3] [Anonymous], PER LIF TABL 2010
  • [4] Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer
    Cooperberg, Matthew R.
    Broering, Jeanette M.
    Carroll, Peter R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : 1117 - 1123
  • [5] Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer
    Draisma, G
    Boer, R
    Otto, SJ
    van der Cruijsen, IW
    Damhuis, RAM
    Schröder, FH
    de Koning, HJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) : 868 - 878
  • [6] National Trends in Prostate Cancer Screening Among Older American Men With Limited 9-Year Life Expectancies
    Drazer, Michael W.
    Prasad, Sandip M.
    Huo, Dezheng
    Schonberg, Mara A.
    Dale, William
    Szmulewitz, Russell Z.
    Eggener, Scott E.
    [J]. CANCER, 2014, 120 (10) : 1491 - 1498
  • [7] Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
    Futterer, Jurgen J.
    Briganti, Alberto
    De Visschere, Pieter
    Emberton, Mark
    Giannarini, Gianluca
    Kirkham, Alex
    Taneja, Samir S.
    Thoeny, Harriet
    Villeirs, Geert
    Villers, Arnauld
    [J]. EUROPEAN UROLOGY, 2015, 68 (06) : 1045 - 1053
  • [8] Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting
    Guazzoni, Giorgio
    Nava, Luciano
    Lazzeri, Massimo
    Scattoni, Vincenzo
    Lughezzani, Giovanni
    Maccagnano, Carmen
    Dorigatti, Fernanda
    Ceriotti, Ferruccio
    Pontillo, Marina
    Bini, Vittorio
    Freschi, Massimo
    Montorsi, Francesco
    Rigatti, Patrizio
    [J]. EUROPEAN UROLOGY, 2011, 60 (02) : 214 - 222
  • [9] Overdiagnosis and Overtreatment of Prostate Cancer
    Loeb, Stacy
    Bjurlin, Marc A.
    Nicholson, Joseph
    Tammela, Teuvo L.
    Penson, David F.
    Carter, H. Ballentine
    Carroll, Peter
    Etzioni, Ruth
    [J]. EUROPEAN UROLOGY, 2014, 65 (06) : 1046 - 1055
  • [10] Development and Internal Validation of a Prostate Health Index Based Nomogram for Predicting Prostate Cancer at Extended Biopsy
    Lughezzani, Giovanni
    Lazzeri, Massimo
    Larcher, Alessandro
    Lista, Giuliana
    Scattoni, Vincenzo
    Cestari, Andrea
    Buffi, Nicolo Maria
    Bini, Vittorio
    Guazzoni, Giorgio
    [J]. JOURNAL OF UROLOGY, 2012, 188 (04) : 1144 - 1150
12